CatalystWireBeta

Directorate Change

In brief · summary, not quotable

Non-Executive Director Bob Beveridge retiring after nine years; Richard Jones appointed as replacement NED and Audit Committee Chair.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your IHC notes

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces the retirement of Bob Beveridge, Non-Executive Director ("NED") who is stepping down after nine years in line with best practice. Bob will be replaced as NED and Chair of the Audit Committee by Richard Jones. The Board wish to thank Bob for his years of service and commitment to Inspiration Healthcare during his tenure and are delighted to be able to appoint Richard to the role. Both changes will come into effect from 31 January 2025.

Richard is a seasoned healthcare and life sciences professional with extensive experience as a board member of publicly listed companies. He has spent more than 20 years serving in both independent NED and Executive Director roles and has acted as a key adviser across a diverse range of public and private companies in the life sciences space. He has expertise across a wide spectrum of Board issues and has worked extensively outside the UK PLC market having completed a US reverse merger as CFO for a UK biotech company in 2019.

Currently he is a Senior Independent Director and Audit Committee Chair of Alliance Pharma PLC, an AIM listed international consumer healthcare company where he is closely involved in all aspects of the business. Formerly, he was Chief Financial Officer ("CFO") and Company Secretary of the UK and Ireland's leading supplier of tele-radiology services, Medica Group Ltd. His CFO and Board experience also includes Mereo Biopharma PLC and Shield Therapeutics PLC.

Roy Davis, Executive Chairman of Inspiration Healthcare said: "We are delighted to welcome Richard on board, and we are excited to be able to tap into his extensive capital markets experience, as well as his in-depth knowledge of the US market where we continue to grow our presence.

"On behalf of the Board, I would like to thank Bob for his dedication and commitment to Inspiration Healthcare over almost a decade. We will be sad to see him go, and we wish him all the very best for his future plans."

Bob Beveridge, outgoing Non-Executive Director said: "I have thoroughly enjoyed my time with the Inspiration Healthcare team over the years. I believe they are at a key transitional phase, and I know they will be a great success. I wish them well for a bright future."

Richard Jones, incoming Non-Executive Director added: "I am looking forward to joining the Board of Inspiration Healthcare and sharing my PLC and life sciences industry expertise with the team."

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Richard Crispin Morgan Jones (aged 58 years) holds / has held the following directorships/partnerships in the last five years:

Current directorships / partnershipsPrevious directorships / partnerships in last 5 years
Alliance Pharma plcGlobal Diagnostics Ireland Ltd
C4X Discovery Holdings LimitedGlobal Retinopathy Screening Ltd
Hampshire Topco LimitedJCA Seminars Limited
Hero Acquisitions LimitedMedica Australia Pty Ltd
HSS Hire Group plcMedica Group Limited
HSS Hire Service Finance LimitedMedica IT Services Limited
RCMJ Consultancy LtdMedica Reporting Finance Limited

Medica Reporting Limited

Medica Reporting Services Limited

Medica US Inc

Med-IDX Pty Ltd

Med-IDX UK Limited

Mereo Biopharma 1 Limited

Mereo Biopharma 2 Limited

Mereo Biopharma 3 Limited

Mereo Biopharma 4 Limited

Mereo Biopharma Group plc

Mereo BioPharma Ireland Limited

Mereo MereoCo Inc

Mereo US Holdings Inc

Moonlight Bidco Limited

Moonlight Midco 1 Limited

Moonlight Midco 2 Limited

Moonlight Topco Limited

Richard Crispin Morgan Jones does not hold any ordinary shares in the capital of the Company. There are no further disclosures to be made in accordance with AIM Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note